A Clinical Study of How Coffee and Tea Affect Enlicitide in Healthy Volunteers (MK-0616-040)
Clinical trial NCT07044479 · COMPLETED
Trial details
- NCT number
- NCT07044479
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-03
- Primary completion
- 2025-08-13
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.